Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 AM EDT
347.00quote price arrow up+1.26 (+0.36%)
Volume
395
Close
345.74quote price arrow down-3.82 (-1.09%)
Volume
6,337,954
52 week range
65.49 - 497.49
Loading...
  • Open352.00
  • Day High356.77
  • Day Low341.37
  • Prev Close345.74
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap139.558B
  • Shares Out403.65M
  • 10 Day Average Volume9.85M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change230.95

KEY STATS

  • Open352.00
  • Day High356.77
  • Day Low341.37
  • Prev Close345.74
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20
  • Market Cap139.558B
  • Shares Out403.65M
  • 10 Day Average Volume9.85M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change230.95

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)43.16
  • Fwd P/E (NTM)7.86
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO2:2602:26
Moderna will be the first trillion dollar health-care company, says Stephen Weiss

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
292.39-2.53-0.86%
ILMN
Illumina Inc
417.19-3.59-0.85%
REGN
Regeneron Pharmaceuticals Inc
592.15+15.95+2.77%
BIIB
Biogen Inc
271.12+1.18+0.44%
GRFS
Grifols SA
13.52-0.14-1.02%